主办:上海医药工业研究院
   中国药学会
   中国化学制药工业协会
ISSN 1001-8255   CN 31-1243/R   ZYGZEA

Current Issue

  • Select all
    |
    Perspectives & Review
  • Perspectives & Review
    CHEN Fang , WANG Jian , LI Mingyan , SHANG Yue, HOU Huimin
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    The pharmaceutical films are thin sheets formed by various methods such as casting or extrusion, which results in a dispersion of the active pharmaceutical ingredients through the film. They are subject to growing research and have received increasing interests recently due to their convenient administration and improved patient compliance. This review summarizes the marketed products of film dosage form, their quality standards, and storage requirements. Besides, the testing methods of quality inspection items including disintegration time and dissolution are discussed. Finally, brief explanations are provided for the revision of general requirements of pharmaceutical films in the general chapter of the Chinese Pharmacopoeia by comparing with the United States Pharmacopoeia, European Pharmacopoeia, and Japanese Pharmacopoeia.
  • Perspectives & Review
    WANG Peng, ZHANG Yong, WANG Donghai, YANG Qingmin
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Orodispersible films are innovative single-layer or multi-layer composite drug-loading films that can be quickly wetted by the patient’s saliva and dissolved in the mouth without the need for drinking water. This review introduces the dosage form characteristics, global development, formulation compositions and process features, research content and general requirements of quality control of orodispersible films. For the quality evaluation of orodispersible films, except for the conventional inspection items of ordinary oral preparations, some special characteristics, such as physical, chemical, and mechanical properties of orodispersible films should also be evaluated based on the dosage form characteristics in order to ensure the safety and effectiveness of the products.
  • Perspectives & Review
    ZHANG Junqi, YANG Liuliu, CHEN Fang
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    The pharmaceutical films have the characteristics of good patient compliance, convenience for carrying and taking, and accurate dosage. 3D printing technology is an additive manufacturing technology based on computer-aided design models, which generally builds objects by layer-by-layer printing and stacking. It has the advantages of providing complex structures, developing compound preparations and personalized medicines. This review gives an overview of the widely used 3D printing technologies in the preparation of pharmaceutical films, including inkjet printing, fused deposition molding, and semi-solid extrusion. Then, the formulation composition and key process parameters of 3D printing technologies are briefly outlined. It is hoped that this review can provide some references for further researches on the application of 3D printing technology in the field of pharmaceutical films.
  • Perspectives & Review
    LI Mingyan, WANG Bing, HE Juntao, ZHANG Huiping, CHEN Fang
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    In this study, a flow-through cell based apparatus was developed to explore the method of dissolution determination for pharmaceutical films. The results of accuracy tests on sampling and temperature controlling showed that the apparatus performed well on accuracy control under different flow rate conditions of 1, 2 and 5 mL/min. Granisetron hydrochloride orodispersible film, asenapine maleate sublingual film, rasagiline mesylate sublingual film and tadalafil orodispersible film were selected as model drugs to verify the fixed method of film, fluid morphology, and tightness of the dissolution cell, and corresponding improvements were proposed. The results indicated that through dispersing the dissolution media with a filter core, fixing the film with a screen mesh, and enhancing the tightness of dissolution cell, this apparatus could achieve primary functions on dissolution with the potential of application universality for different pharmaceutical films and flow rates.
  • Perspectives & Review
    CHEN Fang, JIA Qiuyu, WANG Bing, XIANG Xiaoqiang, WANG Hao
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    A physiologically based pharmacokinetic(PBPK) model of asenapine maleate was developed and verified with the oral cavity compartmental absorption and transit(OCCAT) model and advanced compartmental absorption and transit(ACAT) model of GastroPlusTM software combined with the results of pharmacokinetic study of sublingual films in Beagle dogs. The parameter sensitivity analysis was used to quantify the effects of aqueous solubility and in vitro dissolution(Z-factor value) of asenapine maleate on the bioavailability of asenapine maleate sublingual films, and the in vivo dissolution and absorption behaviors were also simulated and predicted. The results indicated that there were delayed absorption and back-diffusion in oral transmucosal absorption of asenapine maleate. The changes in solubility and dissolution did not have significant influences on the oral transmucosal absorption when the solubility was greater than 6.2 mg/mL and the in vitro dissolution in water at 2 min was more than 70% . Based on the mechanistic analysis and prediction of the PBPK model, it was concluded that the solid dispersion technology in the preparation process of asenapine maleate sublingual films could be simplified. The results of pharmacokinetics in Beagle dogs showed that there were no statistical differences in AUC0→∞(P=0.869), cmax(P=0.902) and tmax(P=0.356) values between the sublingual films obtained before and after the process change. As a result, the PBPK modeling and simulation of asenapine sublingual films could be helpful to establish solubility and in vitro dissolution specifications and then be employed to guide drug research and development and support simplification of the preparation process.
  • Perspectives & Review
    LIU Guomin, ZHAI Hao, CAI Ting,
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    The low solubility of flunarizine hydrochloride(1) can lead to the low oral bioavailability. In order to increase the solubility of 1, 1 nanocrystal suspension was prepared by the antisolvent crystallization method in this study. The orodispersible films containing 1 nanocrystals were then prepared by the solvent casting method. The effects of drug loading and relative molecular weight(Mr: 5×104 - 4×105) of HPMC on the critical quality attributes of the orodispersible films were investigated. The results revealed that the redispersibility of the nanocrystalline orodispersible films was not significantly affected when the drug loading was lower than 40% . However, within the test ranges, the larger the Mr of HPMC, the worse the redispersibility of the 1 nanocrystalline orodispersible films. When the drug loading was in the range of 20% - 30% , 1 nanocrystal was evenly distributed in the films containing HPMC E15, HPMC E50, or HPMC E4M as the film forming material. However, when the drug loading was higher than 40% , 1 nanocrystal tended to aggregate in the films. Furthermore, the results showed a good correlation between the erosion and dissolution performance of the films, where the higher the drug loading and Mr of HPMC resulted in the slower the erosion and dissolution rates of the film.
  • Perspectives & Review
    YANG Liuliu, WANG Bing, HONG Liping, WANG Wenqi, CHEN Fang
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    In order to control the product quality of loratadine(1) orodispersible films and provide references for the establishment of specification for similar dosage forms, a quality standard for 1 orodispersible films had been established based on the guidance principles issued by ICH and NMPA, and referring to the pharmacopoeia standards of 1 oral solid dosage forms and the quality information on orodispersible films marketed abroad, in combination with the characteristics of 1 orodispersible films. Quality inspection and stability investigation of three batches of 1 orodispersible films were carried out. The results showed that the appearance, identification, related substances, dissolution, disintegration time, content, content uniformity and microbial limits of the self-made 1 orodispersible films were in compliance with the quality standard, indicating that the self-made product had good stability. In conclusion, the quality standard provided could adequately control the product quality of 1 orodispersible films.
  • Perspectives & Review
    KANG Xiuyuan, ZHOU Zhen, LI Zhou, FANG Baihuan, GE Qinghua
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    A liquid chromatography coupled to tandem mass spectrometry(LC-MS/MS) method was established for determination of aripiprazole in Beagle dog plasma with diphenhydramine as the internal standard. The detection was conducted with an electrospray ionization(ESI) interface via multiple reaction monitoring(MRM) under positive ionization mode. It was linear for aripiprazole in the concentration range of 0.1 - 100 ng/mL. The method validation tests were carried out. The recoveries were 97.8% - 100.3% , and intra- and inter-day RSDs were respectively less than 3.80% and 6.97% . No significant matrix effects were observed and the analytes were proved to be stable. This validated method was applied to the pharmacokinetics study of the self-made aripiprazole orodispersible films and the commercially available aripiprazole orally disintegrating tablets in Beagle Dogs. The results exhibited the similar pharmacokinetic characteristics between these two dosage forms and the relative bioavailability of the self-made films was (110.1±10.5)% .
  • Perspectives & Review
    LI Hui, WU Xiaoqiang, FANG Liang
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Based on the phase solubility determination results of clonidine in different cyclodextrin derivatives, methyl-β-cyclodextrin was screened out because of the high inclusion efficiency. Then the inclusion complexes with the inclusion ratio of methyl-β-cyclodextrin to clonidine of 1 ∶ 1 were prepared by rotary evaporation method. The drug loading and encapsulation rates of the inclusion complexes were (13.45±0.22)% and (88.78±0.56)% , respectively. After that, the orodispersible films based on the obtained inclusion complexes were prepared by cast coating method. The formulation compositions were optimized by single factor tests, and the results were as follows: PVA 5-88(80% ), inclusion complex(4% ), 1,2-propylene glycol(10% ), and low-substituted hydroxypropyl cellulose(10% ). The quality attributes of the optimized films were determined. The results showed that the thickness, water content, surface pH value, tensile strength and elongation at break of the self-made films were (91.72±1.74)μm, 4.71% , 6.75±0.09, (62.44±3.19)N/mm2, and (107.15±7.02)% , respectively. Finally, the taste masking effect was evaluated by the electronic tongue techniques. The results showed that the taste masking effect of the inclusion complex was better than that of aspartame. In conclusion, cyclodextrin inclusion technology can significantly mask the bitterness of a drug.
  • Perspectives & Review
    LIU Yuanyuan , DU Huanhuan , YIN Min , SHI Bin , HE Dunwei ,
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    The orodispersible films(ODFs) of tandospirone citrate were prepared by solvent casting method. The film-forming materials, taste masking agent and plasticizer were screened and optimized by single factor tests. The optimal formulation was as follows: 10.8% of tandospirone citrate, 37.5% of HPMC E5, 7.5% of hydroxypropyl cellulose, 27.0% of hydroxypropyl-β-cyclodextrin, 15% of glycerin, and 2.2% of sucralose. The obtained ODFs had good film properties with a disintegration time of about 40 s. The requirements for content uniformity and related substances were met. The dissolution rate in water at 15 min exceeded 85% , which was similar to that of the commercially available tablets. The bitterness of the drug was well masked on the basis of the inclusion effect of hydroxypropyl-β-cyclodextrin. The stability tests were conducted under photolysis, high temperature, and high humidity conditions. The results showed that the ODFs had good stability except for high temperature at 60 ℃ . The appearance, drug content and related substances of the ODFs stored under other conditions had not significantly changed. After being stored for one month under accelerated test condition(40 ℃ and 75% of relative humidity), the API crystal form remained stable.
  • Perspectives & Review
    WANG Liu, HAN Shengnan, PENG Hui, TONG Mei, ZHU Gangzhi, HE Xiaoai
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    The pharmacokinetic characteristics of domestically produced tadalafil(1) orodispersible films in healthy male Chinese volunteers and their relative bioavailability compared with tadalafil tablets were investigated. A randomized, open-label, 3-period, Latin square crossover trial under fasting conditions was performed, and 36 volunteers were randomized 1 ∶ 1 ∶ 1 to receive single oral dose of 1 film without water, 1 film or tablet with water. A randomized, open label, 2-period crossover trial under fed conditions was also performed, and 32 volunteers were randomized 1 ∶ 1 to receive 1 film or tablet with water. A LC-MS/MS method was used to determine the concentration of 1 in plasma. Main pharmacokinetic parameters were calculated by WinNonlin 8.1 software and the statistical analysis was conducted with SAS 9.4 software. The results showed that compared with 1 tablet, the 90% confidence intervals for the geometric mean ratios of the main pharmacokinetic parameters(cmax, AUC0→t and AUC0→ ∞ ) of the 1 film in the fasting state were within the range of 80% - 125% . While the 90% confidence interval for the geometric mean ratio of cmax of the 1 film was not within the range of 80% - 125% in the fed state. These results showed that 1 film(with or without water) was bioequivalent to 1 tablets under fasting conditions but not bioequivalent under fed conditions.
  • Perspectives & Review
    WANG Bing, WU Wangping, HE Juntao, YUAN Chunping , CHEN Fang
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    This research conducted a commissioning on the critical components of the film coating machine, by investigating the impact of the feeding height of casting mixture on thickness and weight variation of the blank films, the effect of casting height on film thickness and disintegration time, the influences of air flow rates at inlet and outlet on drying temperature, and the consistency of running speed. Three batches of tadalafil orodispersible films(ODFs) with 100 000 pieces per batch were prepared with the machine in a GMP workshop, and the casting process parameters were verified to evaluate the casting uniformity and stability of the equipment. The results showed that the heating temperature could be steadily controlled within the range of 30 - 120 ℃ , the running speed could be accurately set within the range of 0.1 - 2.0 m/min and the deviations between the measured and set values were within ±1% . Additionally, the equipment offered a maximum output of approximately 480 000 pieces per 8 hours. The thickness of the three batches of ODFs was 60 - 64 μm, and weight variations of three batches were –2.06% to +1.37% , –3.34% to +2.68% , and –1.89% to +2.05% , respectively. There were no significant changes in the thickness and width of the films during the continuous operation of the equipment for 6 hours, and the films sampled from the front, middle and rear sections of the liner performed well on content uniformity with the values of A+2.2S ranging from 2.3 to 7.4. In conclusion, this equipment can basically meet the requirements of the industrial production for pharmaceutical films.
  • Pharmaceutical Management & Information
  • Pharmaceutical Management & Information
    LI Shuai, DONG Zhenglong, WU Hao, ZHUO Yang, CHEN Guiliang
    Abstract ( ) Download PDF ( )   Knowledge map   Save
  • Pharmaceutical Management & Information
    YUAN Lijia, ZHOU Haohui, WANG Yamin, FAN Yi
    Abstract ( ) Download PDF ( )   Knowledge map   Save
  • Pharmaceutical Management & Information
    LIU Jiawei, CHEN Jing, FENG Jiajia, CHENG Hong, QIN Haiqiang, ZHANG Junjian, PENG Xiaoxiang, HU Xin
    Abstract ( ) Download PDF ( )   Knowledge map   Save
  • Pharmaceutical Management & Information
    HE Jiaqi, CHANG Yulan, CHEN Ye, DING Jinxi
    Abstract ( ) Download PDF ( )   Knowledge map   Save
  • Pharmaceutical Management & Information
    XU Yiwen, WANG Miao, LI Yuying, SU Hong
    Abstract ( ) Download PDF ( )   Knowledge map   Save
  • Pharmaceutical Management & Information
    XU Honghao, LIU Ruoying, WANG Jialuo, NA Xin, CHU Shuzhen
    Abstract ( ) Download PDF ( )   Knowledge map   Save
  • Pharmaceutical Management & Information
    YAO Xuefang
    Abstract ( ) Download PDF ( )   Knowledge map   Save